Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Inhibition of MNK-eIF4E mRNA Translational Control Protects Against ERK-Mediated Retinal Ganglion Cell Degeneration
Author Affiliations & Notes
  • Jeremy M Sivak
    University of Toronto, Toronto, Ontario, Canada
    University Health Network, Toronto, Ontario, Canada
  • Alessandra Tuccitto
    University of Toronto, Toronto, Ontario, Canada
    University Health Network, Toronto, Ontario, Canada
  • Margaret Luke
    University of Toronto, Toronto, Ontario, Canada
    University Health Network, Toronto, Ontario, Canada
  • Karen Wigg
    University of Toronto, Toronto, Ontario, Canada
    University Health Network, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships   Jeremy Sivak None; Alessandra Tuccitto None; Margaret Luke None; Karen Wigg None
  • Footnotes
    Support  CIHR Grant PJT168845 and NIH grant R01EY030218
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 697. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jeremy M Sivak, Alessandra Tuccitto, Margaret Luke, Karen Wigg; Inhibition of MNK-eIF4E mRNA Translational Control Protects Against ERK-Mediated Retinal Ganglion Cell Degeneration. Invest. Ophthalmol. Vis. Sci. 2024;65(7):697.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Changes in protein synthesis are inherently linked to retinal ganglion cell (RGC) metabolism and survival. Yet, the specific mechanisms that modify mRNA translation during RGC degeneration are not clear. We have uncovered a pathway linking extracellular induction of the MAPK (mitogen activated protein kinase) ERK to alter translational control in injured RGCs. This signaling is mediated through the activities of MNKs (MAPK interacting serine/threonine kinases), to specifically alter the function of eIF4E (eukaryotic translation initiation factor 4E). eIF4E is a key component of cap-dependent mRNA translation, but exhibits preferences for translating specific subsets of mRNAs in different tissues and contexts. Using next-gen ribosomal profiling (riboseq), we tested whether MAPK-MNK-eIF4E pathway drives altered translation of specific cohorts of mRNAs to impact RGC survival.

Methods : Pharmacologic and genetic tools were used to assess the histological and functional impact of MNK-eIF4E signaling in kainic acid (KA) and intraocular pressure-induced models of RGC degeneration. To determine differentially translated mRNAs, riboseq was performed in retinas of wild-type mice, or a strain containing an eIF4E single amino acid knock-in (KI) that inactivates MNK signaling. Rapid translational changes were assessed following KA injury. Ribosome-protected mRNAs were then purified and sequenced for identification of differentially translated transcripts, followed by informatic and pathways analyses.

Results : In both injury models inhibition of eIF4E signaling was demonstrated to significantly protect RGC survival and function. Ribosomal profiling uncovered injury-related transcripts that were significantly differentially translated in WT retinas after KA treatment, compared to unchallenged controls (p<0.01). Remarkably, of these only 11 of these transcripts were sensitive and specific to ERK-MNK signaling (p<0.01). Informatic analyses identified several pathways involved in neuronal activity.

Conclusions : This work uncovered rapid translational changes in the retina after degenerative injury that are eIF4E-dependent for a subset of genes. This novel area can be further studied to better understand neurodegeneration, and presents an opportunity to selectively fine-tune translation to promote RGC survival and function.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×